Sino Medical Sciences Technology In (688108) — Cash Flow Reinvestment Rate
Sino Medical Sciences Technology In (688108) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥6.63 Million (capex CN¥6.63 Million ) from operating cash flow of CN¥31.52 Million. Check 688108 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sino Medical Sciences Technology In Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Sino Medical Sciences Technology In across 8 annual periods. Explore 688108 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sino Medical Sciences Technology In (2016–2025)
Year-by-year capital reinvestment analysis for Sino Medical Sciences Technology In. For live market cap and broader valuation context, see 688108 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.28x | CN¥45.80 Million | CN¥161.87 Million | CN¥45.80 Million | ▼ -47.0% |
| 2024 | 0.53x | CN¥70.09 Million | CN¥131.24 Million | CN¥70.02 Million | ▼ -88.4% |
| 2023 | 4.59x | CN¥260.71 Million | CN¥56.84 Million | CN¥67.67 Million | ▲ +174.6% |
| 2020 | 1.67x | CN¥117.78 Million | CN¥70.51 Million | CN¥112.78 Million | ▲ +24.2% |
| 2019 | 1.34x | CN¥185.04 Million | CN¥137.61 Million | CN¥180.04 Million | ▼ -63.4% |
| 2018 | 3.68x | CN¥358.87 Million | CN¥97.56 Million | CN¥98.87 Million | ▼ -23.0% |
| 2017 | 4.78x | CN¥336.00 Million | CN¥70.32 Million | CN¥76.25 Million | ▲ +131.5% |
| 2016 | 2.06x | CN¥87.19 Million | CN¥42.24 Million | CN¥44.32 Million | — |